中国药房2025，Vol.36Issue(23)：2893-2898,6.DOI:10.6039/j.issn.1001-0408.2025.23.02
《药品临床综合评价工作流程指南》团体标准解读
Interpretation of the group standard of Guideline for the Workflow of Clinical Comprehensive Evaluation of Drugs
摘要
Abstract
In order to standardize the workflow for the clinical comprehensive evaluation of drugs,enhance the assessment of research evidence,and improve the application value of research outcomes in translational practice,the Chinese Pharmaceutical Association issued the Guideline for the Workflow of Clinical Comprehensive Evaluation of Drugs(T/CLPA 5-2025)in June 2025.The core points include clarifying the concept of clinical comprehensive evaluation of drugs and standardizing the main work processes and technical essentials.This article provides a detailed interpretation of the technical methods for standard formulation,the operational logic of the four core processes(theme selection,evaluation implementation,evidence evaluation,result application transformation),and the key points of core technologies.The aim is to assist medical institution technicians,policymakers and researchers in accurately grasping the connotation of the standards,resolving practical concerns such as process connection and technology application,and enhancing the quality and homogenization of evaluation work.It provides support for the scientific decision-making of healthcare and health,and the rational clinical medication.关键词
药品临床综合评价/工作流程指南/团体标准/解读Key words
clinical comprehensive evaluation of drugs/guideline for the workflow/group standard/interpretation分类
医药卫生引用本文复制引用
段蓉,李正翔..《药品临床综合评价工作流程指南》团体标准解读[J].中国药房,2025,36(23):2893-2898,6.基金项目
天津市药品临床综合评价项目(No.津卫食药[2025]67号) （No.津卫食药[2025]67号）
